肝细胞肝癌代谢异常相关问题的研究现状及展望
Research Status and Prospect of Metabolic Abnormalities in Hepatocellular Carcinoma
摘要: 肝细胞肝癌(下简称“肝癌”)作为目前全球第四大死因,诊断与治疗都尚未达到一个理想的水平。肝脏作为人体最大也是最重要的代谢器官之一,在人体糖质、脂肪酸、维生素等人体常见元素的代谢中起到重要的作用。同时,代谢异常相关疾病发病率逐渐上升,其中不少疾病已经成为肝脏相关疾病的高危因素、起因等。代谢相关疾病与肝癌的相关研究已多见报道。本文从脂肪酸代谢、糖质代谢以及维生素代谢三个角度,对肝癌与代谢异常相关问题做简要的阐述。
Abstract: As the fourth leading cause of death in the world, liver cancer, of which hepatocellular carcinoma (HCC) is the dominant variety, has not yet reached an ideal level of diagnosis and treatment. As one of the largest and most important metabolic organs of the human body, the liver plays an important role in the metabolism of glucose, lipids, proteins, vitamins and hormones. At the same time, the incidence of metabolic abnormalities-related diseases is gradually increasing. Many of them have become high-risk factors and causes of liver diseases. Researches on metabolism-related diseases and liver cancer have been reported frequently. This article will briefly explain the problems related to liver cancer and abnormal metabolism from the perspectives of lipid metabolism, glucose metabolism and vitamin metabolism.
文章引用:祁峰, 龚建平. 肝细胞肝癌代谢异常相关问题的研究现状及展望[J]. 临床医学进展, 2021, 11(6): 2724-2729. https://doi.org/10.12677/ACM.2021.116394

参考文献

[1] Mcglynn, K., Petrick, J. and El-Serag, H. (2021) Epidemiology of Hepatocellular Carcinoma. Hepatology (Baltimore, MD), 73, 4-13. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, J., Hainaut, P., Gores, G., et al. (2019) A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management. Nature Reviews Gastroenterology & Hepatology, 16, 589-604. [Google Scholar] [CrossRef] [PubMed]
[3] Yin, Z. and Li, X. (2020) Immunotherapy for Hepatocellular Carcinoma. Cancer Letters, 470, 8-17. [Google Scholar] [CrossRef] [PubMed]
[4] Bosetti, C., Turati, F. and La Vecchia, C. (2014) Hepatocellular Carcinoma Epidemiology. Best Practice & Research Clinical Gastroenterology, 28, 753-770. [Google Scholar] [CrossRef] [PubMed]
[5] Rinella, M. (2015) Nonalcoholic Fatty Liver Disease: A Systematic Review. JAMA, 313, 2263-2273. [Google Scholar] [CrossRef] [PubMed]
[6] Dyson, J., Jaques, B., Chattopadyhay, D., et al. (2014) Hepatocellular Cancer: The Impact of Obesity, Type 2 Diabetes and a Multidisciplinary Team. Journal of Hepatology, 60, 110-117. [Google Scholar] [CrossRef] [PubMed]
[7] Naruse, K., Tang, W. and Makuuch, M. (2007) Artificial and Bioartificial Liver Support: A Review of Perfusion Treatment for Hepatic Failure Patients. World Journal of Gastroenterology, 13, 1516-1521. [Google Scholar] [CrossRef] [PubMed]
[8] Green, C., Pramfalk, C., Morten, K., et al. (2015) From Whole Body to Cellular Models of Hepatic Triglyceride Metabolism: Man Has Got to Know His Limitations. American Journal of Physiology Endocrinology and Metabolism, 308, E1-E20. [Google Scholar] [CrossRef] [PubMed]
[9] Kato, A., Ando, K., Tamura, G., et al. (1971) Effects of Some Fatty Acid Esters on the Viability and Transplantability of Ehrlich Ascites Tumor Cells. Cancer Research, 31, 501-504.
[10] Mcgee, R. and Spector, A. (1974) Short-Term Effects of Free Fatty Acids on the Regulation of Fatty Acid Biosynthesis in Ehrlich Ascites Tumor Cells. Cancer Research, 34, 3355-3362.
[11] Chen, Y., Liu, B., Tang, D., et al. (1992) Fatty Acid Modulation of Tumor Cell-Platelet-Vessel Wall Interaction. Cancer Metastasis Reviews, 11, 389-409. [Google Scholar] [CrossRef
[12] Honn, K., Nelson, K., Renaud, C., et al. (1992) Fatty Acid Modulation of Tumor Cell Adhesion to Microvessel Endothelium and Experimental Metastasis. Prostaglandins, 44, 413-429. [Google Scholar] [CrossRef
[13] Feldstein, A. (2010) Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease, 30, 391-401. [Google Scholar] [CrossRef] [PubMed]
[14] Adams, L., Lymp, J., St. Sauver, J., et al. (2005) The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Gastroenterology, 129, 113-121. [Google Scholar] [CrossRef] [PubMed]
[15] Yang, Y., Yang, X., Lin, Y., et al. (2020) LASS2 Regulates Hepatocyte Steatosis by Interacting with NDUFS2/OXPHOS Related Proteins. Biochemical and Biophysical Research Communications, 526, 871-879. [Google Scholar] [CrossRef] [PubMed]
[16] Yin, F., Sharen, G., Yuan, F., et al. (2017) TIP30 Regulates Lipid Metabolism in Hepatocellular Carcinoma by Regulating SREBP1 through the Akt/mTOR Signaling Pathway. Oncogenesis, 6, e347. [Google Scholar] [CrossRef] [PubMed]
[17] Calle, E., Rodriguez, C., Walker-Thurmond, K., et al. (2003) Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. The New England Journal of Medicine, 348, 1625-1638. [Google Scholar] [CrossRef
[18] Davila, J., Morgan, R., Shaib, Y., et al. (2005) Diabetes Increases the Risk of Hepatocellular Carcinoma in the United States: A Population Based Case Control Study. Gut, 54, 533-539. [Google Scholar] [CrossRef] [PubMed]
[19] Savage, D. and Semple, R. (2010) Recent Insights into Fatty Liver, Metabolic Dyslipidaemia and Their Links to Insulin Resistance. Current Opinion in Lipidology, 21, 329-336. [Google Scholar] [CrossRef
[20] Chalasani, N., Younossi, Z., Lavine, J., et al. (2012) The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology (Baltimore, MD), 55, 2005-2023. [Google Scholar] [CrossRef] [PubMed]
[21] Day, C. and James, O. (1998) Steatohepatitis: A Tale of Two “Hits”? Gastroenterology, 114, 842-845. [Google Scholar] [CrossRef
[22] Warburg, O. (1956) On the Origin of Cancer Cells. Science (New York, NY), 123, 309-314. [Google Scholar] [CrossRef] [PubMed]
[23] Simon, T., King, L., Chong, D., et al. (2018) Diabetes, Metabolic Comorbidities, and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies. Hepatology (Baltimore, MD), 67, 1797-806. [Google Scholar] [CrossRef] [PubMed]
[24] Luo, F., Liu, X., Ling, M., et al. (2016) The lncRNA MALAT1, Acting through HIF-1α Stabilization, Enhances Arsenite-Induced Glycolysis in Human Hepatic L-02 Cells. Biochimica et Biophysica Acta, 1862, 1685-1695. [Google Scholar] [CrossRef] [PubMed]
[25] Wei, S., Fan, Q., Yang, L., et al. (2017) Promotion of Glycolysis by HOTAIR through GLUT1 Upregulation via mTOR Signaling. Oncology Reports, 38, 1902-1908. [Google Scholar] [CrossRef] [PubMed]
[26] Huang, Y., Cai, X., Qiu, M., et al. (2014) Prediabetes and the Risk of Cancer: A Meta-Analysis. Diabetologia, 57, 2261-2269. [Google Scholar] [CrossRef] [PubMed]
[27] Yan, Y., Xu, H., Zhang, L., et al. (2019) RRAD Suppresses the Warburg Effect by Downregulating ACTG1 in Hepatocellular Carcinoma. OncoTargets and Therapy, 12, 1691-1703. [Google Scholar] [CrossRef
[28] Apetoh, L., Ghiringhelli, F., Tesniere, A., et al. (2007) Toll-Like Receptor 4-Dependent Contribution of the Immune System to Anticancer Chemotherapy and Radiotherapy. Nature Medicine, 13, 1050-1059. [Google Scholar] [CrossRef] [PubMed]
[29] Chowdhury, T.A. (2010) Diabetes and Cancer. QJM: Monthly Journal of the Association of Physicians, 103, 905-915. [Google Scholar] [CrossRef] [PubMed]
[30] Jemal, A., Bray, F., Center, M., et al. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. [Google Scholar] [CrossRef] [PubMed]
[31] Giovannucci, E., Harlan, D., Archer, M., et al. (2010) Diabetes and Cancer: A Consensus Report. Diabetes Care, 33, 1674-1685. [Google Scholar] [CrossRef] [PubMed]
[32] Maiuri, M., Tasdemir, E., Criollo, A., et al. (2009) Control of Autophagy by Oncogenes and Tumor Suppressor Genes. Cell Death and Differentiation, 16, 87-93. [Google Scholar] [CrossRef] [PubMed]
[33] Vigneri, P., Frasca, F., Sciacca, L., et al. (2009) Diabetes and Cancer. Endocrine-Related Cancer, 16, 1103-1123. [Google Scholar] [CrossRef
[34] Mccullough, M., Patel, A., Kushi, L., et al. (2011) Following Cancer Prevention Guidelines Reduces Risk of Cancer, Cardiovascular Disease, and All-Cause Mortality. Cancer Epidemiology, Biomarkers & Prevention, 20, 1089-1097. [Google Scholar] [CrossRef
[35] Willett, W. (2008) Nutrition and Cancer: The Search Continues. Nutrition and Cancer, 60, 557-559. [Google Scholar] [CrossRef] [PubMed]
[36] Di Masi, A., Leboffe, L., De Marinis, E., et al. (2015) Retinoic Acid Receptors: From Molecular Mechanisms to Cancer Therapy. Molecular Aspects of Medicine, 41, 1-115. [Google Scholar] [CrossRef] [PubMed]
[37] Yan, T., Wu, H., Zhang, H., et al. (2010) Oncogenic Potential of Retinoic Acid Receptor-Gamma in Hepatocellular Carcinoma. Cancer Research, 70, 2285-2295. [Google Scholar] [CrossRef
[38] Matsumoto, K., Okano, J., Nagahara, T., et al. (2006) Apoptosis of Liver Cancer Cells by Vitamin K2 and Enhancement by MEK Inhibition. International Journal of Oncology, 29, 1501-1508. [Google Scholar] [CrossRef
[39] Yang, C. and Han, L. (2010) Knockdown of Beclin 1 Inhibits Vitamin K3-Induced Autophagy, But Promotes Apoptosis of Human Hepatoma SMMC-7721 Cells. Molecular Medicine Reports, 3, 801-807. [Google Scholar] [CrossRef] [PubMed]
[40] Chun, Y., Lee, B., Yang, S., et al. (2001) Induction of Cytochrome P450 1A1 Gene Expression by a Vitamin K3 Analog in Mouse Hepatoma Hepa-1c1c7 Cells. Molecules and Cells, 12, 190-196.
[41] Wang, J., Abnet, C., Chen, W., et al. (2013) Association between Serum 25(OH) Vitamin D, Incident Liver Cancer and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case-Control Study. British Journal of Cancer, 109, 1997-2004. [Google Scholar] [CrossRef] [PubMed]
[42] Wibaux, C., Legroux-Gerot, I., Dharancy, S., et al. (2011) Assessing Bone Status in Patients Awaiting Liver Transplantation. Joint Bone Spine, 78, 387-391. [Google Scholar] [CrossRef] [PubMed]
[43] Calvisi, D., Ladu, S., Hironaka, K., et al. (2004) Vitamin E Down-Modulates iNOS and NADPH Oxidase in c-Myc/TGF-Alpha Transgenic Mouse Model of Liver Cancer. Journal of Hepatology, 41, 815-822. [Google Scholar] [CrossRef] [PubMed]
[44] Factor, V., Laskowska, D., Jensen, M., et al. (2000) Vitamin E Reduces Chromosomal Damage and Inhibits Hepatic Tumor Formation in a Transgenic Mouse Model. Proceedings of the National Academy of Sciences of the United States of America, 97, 2196-2201. [Google Scholar] [CrossRef] [PubMed]
[45] Zhang, W., Shu, X., Li, H., et al. (2012) Vitamin Intake and Liver Cancer Risk: A Report from Two Cohort Studies in China. Journal of the National Cancer Institute, 104, 1174-1182. [Google Scholar] [CrossRef] [PubMed]